Concepedia

Publication | Open Access

Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer

413

Citations

32

References

2019

Year

Abstract

ClinicalTrials.gov identifier: NCT02657889.

References

YearCitations

Page 1